Subject of the day
SHL.DE
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS to increase product lifecycle with industrial AI. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
| Line | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 |
|---|---|---|---|---|
| Revenue | $5.48B | $5.91B | $5.66B | $5.40B |
| Gross profit | $2.15B | $2.32B | $2.18B | $2.08B |
| Operating income | $697.00M | $844.00M | $732.00M | $677.00M |
| Net income | $474.00M | $530.00M | $552.00M | $449.00M |
| Diluted EPS | 0.42 | — | 0.49 | 0.40 |
| Free cash flow | $810.00M | $198.00M | $844.00M | $331.00M |
| CapEx | -$170.00M | -$195.00M | -$191.00M | -$161.00M |
$39.03
▼ -0.56 (-1.4%)
| 52w hi | $48.37 |
|---|---|
| 52w lo | $33.40 |
| Vol | 570.53K |
| As of | Aug 13 |
Our score +0.16
| Short | -0.12 |
|---|---|
| Medium | +0.28 |
| Long | +0.50 |
computed 2026-08-13
Siemens Healthineers AG
Healthcare · Medical Devices
| Market cap | $43.69B |
|---|---|
| Enterprise value | $56.22B |
| Trailing P/E | 19.82x |
| Forward P/E | 16.46x |
| EV / EBITDA | 13.98x |
| P / S (ttm) | 1.89x |
| Profit margin | 9.6% |
| Return on equity | 12.1% |
| Revenue growth | +1.8% |
| Earnings growth | +22.4% |
| Debt / equity | 78.30 |
| Beta vs SPX | 0.33 |
|---|---|
| Corr SPX | 0.22 |
| Annual vol | 24.2% |
| Annual ret | -13.1% |
| Sharpe | -0.54 |
| Max DD | -44.0% |
Window: 504 trading days (489 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.33 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $39.29 | $39.34 | $38.95 | — | 570.53K |
| Aug 12 | $39.47 | $39.75 | $39.03 | $39.03 | 727.95K |
| Aug 11 | $39.01 | $39.76 | $38.75 | $39.59 | 913.45K |
| Aug 10 | $39.50 | $39.51 | $38.75 | $39.17 | 813.81K |
| Aug 7 | $39.30 | $39.74 | $39.10 | $39.51 | 771.63K |